Deroisy R - Search Results

1

1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin.

Reginster JY, Denis D, Albert A, Deroisy R, Lecart MP, Fontaine MA, Lambelin P, Franchimont P. Reginster JY, et al. Among authors: deroisy r. Lancet. 1987 Dec 26;2(8574):1481-3. doi: 10.1016/s0140-6736(87)92619-5. Lancet. 1987. PMID: 2892047 Clinical Trial.

2

Minimal levels of serum estradiol prevent postmenopausal bone loss.

Reginster JY, Sarlet N, Deroisy R, Albert A, Gaspard U, Franchimont P. Reginster JY, et al. Among authors: deroisy r. Calcif Tissue Int. 1992 Nov;51(5):340-3. doi: 10.1007/BF00316876. Calcif Tissue Int. 1992. PMID: 1458336 Clinical Trial.

3

Calcitonin and postmenopausal bone loss.

Reginster JY, Deroisy R, Lecart MP, Sarlet N, Fontaine MA, Albert A, Franchimont P. Reginster JY, et al. Among authors: deroisy r. Exp Gerontol. 1990;25(3-4):349-56. doi: 10.1016/0531-5565(90)90072-a. Exp Gerontol. 1990. PMID: 2226670

4

Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone.

Reginster JY, Gennari C, Mautalen C, Deroisy R, Denis D, Lecart MP, Vandalem JL, Collette J, Franchimont P. Reginster JY, et al. Among authors: deroisy r. Scand J Rheumatol. 1990;19(1):83-6. doi: 10.3109/03009749009092626. Scand J Rheumatol. 1990. PMID: 2309107 No abstract available.

5

Prevention of postmenopausal bone loss by tiludronate.

Reginster JY, Lecart MP, Deroisy R, Sarlet N, Denis D, Ethgen D, Collette J, Franchimont P. Reginster JY, et al. Among authors: deroisy r. Lancet. 1989 Dec 23-30;2(8678-8679):1469-71. doi: 10.1016/s0140-6736(89)92927-9. Lancet. 1989. PMID: 2574764 Clinical Trial.

6

Is there any place for salmon calcitonin in prevention of postmenopausal bone loss?

Reginster JY, Deroisy R, Denis D, Lecart MP, Sarlet N, Franchimont P. Reginster JY, et al. Among authors: deroisy r. Gynecol Endocrinol. 1988 Sep;2(3):195-204. doi: 10.3109/09513599809029344. Gynecol Endocrinol. 1988. PMID: 3067545 Review. No abstract available.

7

Prevention of postmenopausal bone loss by rectal calcitonin.

Reginster JY, Jupsin I, Deroisy R, Biquet I, Franchimont N, Franchimont P. Reginster JY, et al. Among authors: deroisy r. Calcif Tissue Int. 1995 Jun;56(6):539-42. doi: 10.1007/BF00298586. Calcif Tissue Int. 1995. PMID: 7648483 Clinical Trial.

8

A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.

Reginster JY, Deroisy R, Lecart MP, Sarlet N, Zegels B, Jupsin I, de Longueville M, Franchimont P. Reginster JY, et al. Among authors: deroisy r. Am J Med. 1995 May;98(5):452-8. doi: 10.1016/S0002-9343(99)80344-1. Am J Med. 1995. PMID: 7733123 Clinical Trial.

9

A 5-year controlled randomized study of prevention of postmenopausal trabecular bone loss with nasal salmon calcitonin and calcium.

Reginster JY, Meurmans L, Deroisy R, Jupsin I, Biquet I, Albert A, Franchimont P. Reginster JY, et al. Among authors: deroisy r. Eur J Clin Invest. 1994 Aug;24(8):565-9. doi: 10.1111/j.1365-2362.1994.tb01108.x. Eur J Clin Invest. 1994. PMID: 7982445 Clinical Trial.

10

Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin.

Reginster JY, Denis D, Deroisy R, Lecart MP, De Longueville M, Zegels B, Sarlet N, Noirfalisse P, Franchimont P. Reginster JY, et al. Among authors: deroisy r. J Bone Miner Res. 1994 Jan;9(1):69-73. doi: 10.1002/jbmr.5650090110. J Bone Miner Res. 1994. PMID: 8154311 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page